Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This company is doing good things in a place that needs help
Emerging World Pharma Inc. Strategic Partner African Global Pharma GH Receives Ghana Food and Drug Board Packaging and Insert...
Date : 12/06/2012 @ 8:30AM
Source : MarketWire
Stock : Emerging World Pharma, Inc. (PL) (EWPI)
Quote : 0.003 0.0 (0.00%) @ 9:30AM
Emerging World Pharma Inc. Strategic Partner African Global Pharma GH Receives Ghana Food and Drug Board Packaging and Insert...
Print
Alert
Emerging World Pharma, Inc. (PL) (USOTC:EWPI)
Intraday Stock Chart
Today : Thursday 6 December 2012
Click Here for more Emerging World Pharma, Inc. (PL) Charts.
Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) has received approvals of its packaging and inserts for its lead OTC drug "Paracetamol" an over the counter analgesic drug. The Company has made submissions to the FDB labs for testing and awaits final approval from the national regulator before they can market and distribute the medicine within the country. The Company hopes to receive final approval before the end of 2012.
About African Global Pharma, Ghana
African Global Pharma (Ghana) Limited is an affiliated company of African Global Pharma Corp. of Canada with business partnership with the Catholic Diocese of Sunyani to distribute all our manufactured drugs to the Catholic Mission Hospitals. African Global Pharma's production facility in Sunyani, Ghana was fully rehabilitated and built by African Global Pharma Corp, Canada. The plant and its operations are headquartered in Sunyani at the Diocesan Bldg.
For more on AGP click here http://www.globalpharmacorp.ca/african-gp-ghana.html
About Emerging World Pharma Inc.
Emerging World Pharma Inc. is an investor in generic based pharmaceutical companies manufacturing within developing nations.
The company focuses its investments on generic pharmaceutical companies that have contracts with three major buyer groups; church, government and wholesalers. Market research shows that these branches are the most secure, protected and reputable for the distribution of medicines.
For more on Emerging World Pharma Inc. click here http://www.emergingpharma.com/
Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.
Contact:
Joel Everret
Emerging World Pharma Inc.
Investor Relations Division
703-646-2633
Email: info@emergingpharma.com
Website: http://www.emergingpharma.com/
what does the board have to say bout the news today?
where did everyone go?
news and suspension lol.....
pos
EWPI: SEC Suspension:
http://www.sec.gov/litigation/suspensions/2012/34-68367.pdf
ORDER:
http://www.sec.gov/litigation/suspensions/2012/34-68367-o.pdf
EWPI: Very nice 10Q released today by the company.
119MM OS for EWPI according to 10Q. Nice!
chart is oversold. if epwi gets news of drug approval in Africa, could be some major gains to be had imo.
with a facility already producing a variety of drugs in ghana, ewpi's investment should prove fruitful upon drug administrations approval.
malaria investment sounds like a real winner imo. go ewpi
EWPI Partners: Church, and other NGO (non-government), and wholesalers.
ewpi investments are numerous as per the Q filing, set to make major money imo upon success of the various enterprises.
EWPI float under 33m
nice EWPI transparency with Q filing
EWPI
Quarterly Report
Date : 12/05/2012 @ 1:56PM
Source : OTC Markets
Stock : Emerging World Pharma, Inc. (PL) (EWPI)
Quote : 0.0031 -0.0013 (-29.55%) @ 1:06PM
Quarterly Report
Print
Alert
Wed, Dec 05, 2012 01:56 - Emerging World Pharma, Inc. (EWPI: OTC Link) released their Quarterly Report. To read the complete report, please visit: https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=96106.
Emerging World Pharma, Inc. (PL) (USOTC:EWPI)
Historical Stock Chart
1 Year : From Dec 2011 to Dec 2012
Click Here for more Emerging World Pharma, Inc. (PL) Charts.
Emerging World Pharma, Inc. (PL) (USOTC:EWPI)
Intraday Stock Chart
Today : Wednesday 5 December 2012
Click Here for more Emerging World Pharma, Inc. (PL) Charts.
sounds like a plausible plan to me. go ewpi. bottom bounce from here?
Would think so. 25 days or so left in December. Would think EWPI management wants to wrap things up before the holidays?
agreed, we are down to the 'wire' on the time frame they expected. ewpi could end the year with great news there
or maybe some updates on this approval?
Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) has informed us that the Food and Drugs Board of Ghana approval of the anti-malarial pharmaceutical Gloderp® is in the final stages of the registration process with the company anticipating full approval before this quarter end.
L2 thin to 005 which is breakout point for possible 01 test - ewpi
broke 01 back in nov, can ewpi do it again?
LIL blast of volume and its gone!
EWPI
facility already up and running, will make it easy to add on new products to that line. go EWPI!
Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) is negotiating an agreement to distribute our full line of pharmaceutical products to several West African countries.
This is the first endeavour for AGP to broaden our market base outside of Ghana. The current line of medicines being produced in AGP's Ghana manufacturing facility are Glaten® (anti-hypertensive), Glibenclamide (anti-diabetic), Globartem®, Gloderp (anti-malarials) and Paracetamol (pain relieving analgesic).
Paid promoters...stock drops.
LOL
Nice job fellas
Access to appropriate anti-malarial drugs remains inadequate as has been shown by recent household studies in several African countries.
Moreover, scarce data exist on the availability (in terms of concentration and pricing) of different forms of ACT in many areas across sub-Saharan Africa.
EWPI
http://www.malariajournal.com/content/9/S1/S1
Malaria Market Globally and in Africa:
Globally, 247 million clinical episodes of malaria are estimated to occur every year, of which 86% are in sub-Saharan Africa.
Of more than 767,000 (5th-95th percentiles: 621,000–902,000) Africans who are estimated to have died from malaria in 2008, 88% were children under five years of age, which equals to one child dying of malaria every 45 seconds.
EWPI has a huge opportunity here if they can execute!
http://www.malariajournal.com/content/9/S1/S1
It looks like a keeper imo
$EWPI
hoping for some ewpi volume here.
It's growing like crazy
$EWPI
An entrepreneur in GHANA can set up a chemical and pharmaceutical processing plant within the manufacturing sector as well as venture into the Health Service Delivery sub-sector within the infrastructural facilities sector.
The need to attract investors into the pharmaceuticals sub-sector has become so imperative in view of challenges brought about by diseases such as HIV/AIDS, malaria, etc.
EWPI trying to capitalize on this.
http://www.ghanaembassy.ch/trade/pharma.html
Hoping to see some movement on EWPI as well.
Generic drug use is growing worldwide.
Ghana Investment Guarantees
The constitution of Ghana provides absolute guarantee to all companies established in the country.
Ghana is signatory to the MIGA convention;
Ghana’s Pharmaceutical sub-sector is accessible to all potential investors from Switzerland with very attractive incentive packages.
There exists a vibrant corps of local investors in the sub-sector ready to partner potential investors to take advantage of the huge West African market, using Ghana, the most politically stable country in West Africa, as gateway to the sub-region.
http://www.ghanaembassy.ch/trade/pharma.html
EWPI could benefit from all of this.
Ghana Investment Guarantees
The constitution of Ghana provides absolute guarantee to all companies established in the country.
Ghana is signatory to the MIGA convention;
Ghana’s Pharmaceutical sub-sector is accessible to all potential investors from Switzerland with very attractive incentive packages.
There exists a vibrant corps of local investors in the sub-sector ready to partner potential investors to take advantage of the huge West African market, using Ghana, the most politically stable country in West Africa, as gateway to the sub-region.
http://www.ghanaembassy.ch/trade/pharma.html
EWPI could benefit from all of this.
Should see some nice movement today imo
$EWPI
Same here. Pharma is my favorie sector. EWPI is in a great segment.
Same here, thin on the ask
EWPI
Doin good.. watching closely here
$EWPI
Followers
|
35
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2375
|
Created
|
04/04/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |